Abcellera announces four presentations on t-cell engagers at aacr 2024

Vancouver, british columbia--(business wire)---- $abcl--abcellera (nasdaq: abcl) today announced that its scientists will present four posters with data from its t-cell engager programs and platform at the american association for cancer research (aacr) annual meeting 2024, to be held april 5 to 10 at the san diego convention center. with its t-cell engager platform, abcellera is expanding therapeutic opportunities for this modality by generating molecules with the potential for improved efficacy and saf.
ABCL Ratings Summary
ABCL Quant Ranking